Codes / ICD10CM / E70.40

E70.40 Disorders of histidine metabolism, unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Disorders of histidine metabolism, unspecified (ICD-10 Code: E70.40)

Summary

Disorders of histidine metabolism, unspecified, are rare genetic conditions that disrupt the body's ability to process the amino acid histidine. These disorders can lead to the accumulation of toxic metabolites, causing neurological, developmental, and systemic complications. Early detection and management are critical to mitigate long-term effects.

Causes

These disorders are caused by genetic mutations that impair enzymes involved in histidine metabolism. The mutations prevent the proper breakdown or utilization of histidine, leading to the buildup of harmful substances. Inheritance patterns vary, with some conditions following autosomal recessive or X-linked transmission.

Risk Factors

  • Genetic predisposition; family history of metabolic disorders.
  • Consanguinity (parents who are close relatives).
  • Certain ethnic groups with higher carrier rates for specific mutations.

Symptoms

  • Neurological issues, such as developmental delay, intellectual disability, or seizures.
  • Behavioral changes, including irritability or hyperactivity.
  • Physical symptoms like skin rashes or abnormal body odor.
  • Growth retardation or failure to thrive in severe cases.

Diagnosis

Diagnosis typically involves biochemical testing to measure histidine and its metabolites in blood or urine. Confirmatory testing may include genetic analysis to identify specific mutations. Newborn screening programs may detect elevated levels of histidine or related metabolites.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. Dietary modifications, such as restricting histidine intake, may be recommended. Medications or supplements to address metabolic imbalances are sometimes used. Regular monitoring by a metabolic specialist is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of the disorder and the timeliness of intervention. Early diagnosis and adherence to treatment can improve outcomes. Long-term follow-up with a multidisciplinary team (e.g., neurologists, dietitians) is necessary to monitor development and adjust management plans.

Complications

Untreated or poorly managed disorders can lead to severe neurological damage, intellectual disability, seizures, or organ dysfunction. Growth delays and behavioral issues may persist despite treatment.

Lifestyle & Prevention

  • Follow a prescribed diet low in histidine, as guided by a metabolic specialist.
  • Avoid triggers that may exacerbate symptoms (e.g., certain foods or medications).
  • Maintain regular medical appointments for monitoring and adjustments to the care plan.

When to Seek Professional Help

Seek immediate medical attention if symptoms worsen, such as increased seizures, severe developmental regression, or unexplained lethargy. Routine follow-up with a metabolic specialist is recommended to address concerns promptly.

Tips for Medical Coders

Use E70.40 for unspecified disorders of histidine metabolism when the specific subtype is not documented. Ensure documentation supports the absence of more detailed information (e.g., no mention of a specific enzyme deficiency or clinical subtype). Verify that the code aligns with the patient's diagnosis and clinical findings.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

E70.40 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.